aiming to improve survival in cancer.
Latest News
November 7, 2024: MaaT Pharma to Present Updates from Early Access Program at the 2024 ASH Annual Meeting Demonstrating Prolonged Long-Term Survival in Patients Receiving MaaT013 in aGvHD
Like what you see? See more posts
Join the MaaT Pharma adventure!
Bring your talents, your passion and join an inclusive, creative, and multidisciplinary team. We aim to leverage the potential of microbiome to improve the treatment of patients with cancer.
Learn more about our values, our environment and see what we have to offer to you!